Clinical & Experimental Cardiology
Open Access
ISSN: 2155-9880
+44 1300 500008
ISSN: 2155-9880
+44 1300 500008
Training and Research in Health Sciences Unit, University of Saint-Louis, St. Louis, Missouri, USA
Review
Long-Term Effect of Bromocriptine on Left Ventricle Systolic Function Recovery in Peripartum Cardiomyopathy: A Prospective Longitudinal Study
Author(s): Fatou Aw*, Simon Antoine Sarr, Joseph Salvador Mingou, Rim Khaled, Malick Kane, Ndoye Gueye, Marguerite Téning Diouf, Désiré Alain Affangla, Youssou Diouf, Mohamed Leye, Khadimu Rassoul Diop, Serigne Mor Beye, Aliou Alassane Ngaïdé, Dioum Momar, Malik Bodian, Momo Banda Ndiaye, Alassane Mbaye, Adama Kane, Maboury Diao, Adama Faye and Adama Kane
Introduction: The treatment of peripartum cardiomyopathy follows the main principles of the treatment of heart failure with reduced ejection fraction. To date, the adoption of bromocriptine as a legitimate option in the PPCM treatement is widely variable across the world. The main objective of this work was to evaluate the efficacy of bromocriptine in improving left ventricular function in addition to conventional treatment of peripartum cardiomyopathy. Methodology:This was a longitudinal, prospective quasi-experimental study conducted in patients followed at the cardiology clinic of Aristide Le Dantec Hospital for peripartum cardiomyopathy from January 1, 2017 to January 01, 2021, with a total duration of 48 months. We made a consecutive and exhaustive recruitment of all patients admitted during the study period. This study received the approval of the ethics committee of the Cheikh .. View More»
DOI:
10.35248/2155-9880.22.13.756